2812 related articles for article (PubMed ID: 23611316)
1. Contrast-enhanced ultrasound using SonoVue® (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver metastases: a systematic review and cost-effectiveness analysis.
Westwood M; Joore M; Grutters J; Redekop K; Armstrong N; Lee K; Gloy V; Raatz H; Misso K; Severens J; Kleijnen J
Health Technol Assess; 2013 Apr; 17(16):1-243. PubMed ID: 23611316
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis value of focal liver lesions with SonoVue®-enhanced ultrasound compared with contrast-enhanced computed tomography and contrast-enhanced MRI: a meta-analysis.
Guang Y; Xie L; Ding H; Cai A; Huang Y
J Cancer Res Clin Oncol; 2011 Nov; 137(11):1595-605. PubMed ID: 21850382
[TBL] [Abstract][Full Text] [Related]
3. Contrast-enhanced ultrasound can guide the therapeutic strategy by improving the detection of colorectal liver metastases.
Sawatzki M; Güller U; Güsewell S; Husarik DB; Semela D; Brand S
J Hepatol; 2021 Feb; 74(2):419-427. PubMed ID: 33065168
[TBL] [Abstract][Full Text] [Related]
4. Image fusion of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) using volume navigation for detection, characterization and planning of therapeutic interventions of liver tumors.
Rennert J; Georgieva M; Schreyer AG; Jung W; Ross C; Stroszczynski C; Jung EM
Clin Hemorheol Microcirc; 2011; 49(1-4):67-81. PubMed ID: 22214679
[TBL] [Abstract][Full Text] [Related]
5. Comparison of contrast enhanced ultrasound and contrast enhanced CT or MRI in monitoring percutaneous thermal ablation procedure in patients with hepatocellular carcinoma: a multi-center study in China.
Lu MD; Yu XL; Li AH; Jiang TA; Chen MH; Zhao BZ; Zhou XD; Wang JR
Ultrasound Med Biol; 2007 Nov; 33(11):1736-49. PubMed ID: 17629608
[TBL] [Abstract][Full Text] [Related]
6. Ultrasound, CT, MRI, or PET-CT for staging and re-staging of adults with cutaneous melanoma.
Dinnes J; Ferrante di Ruffano L; Takwoingi Y; Cheung ST; Nathan P; Matin RN; Chuchu N; Chan SA; Durack A; Bayliss SE; Gulati A; Patel L; Davenport C; Godfrey K; Subesinghe M; Traill Z; Deeks JJ; Williams HC;
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD012806. PubMed ID: 31260100
[TBL] [Abstract][Full Text] [Related]
7. On-Site Diagnostic Ability of CEUS/CT/MRI for Hepatocellular Carcinoma (2019-2022): A Multicenter Study.
Yang Q; Zheng R; Zhou J; Tang L; Zhang R; Jiang T; Jing X; Liao J; Cheng W; Zhao C; Liu C; Dietrich CF; Cui X; Cai W; Wu J; Yu F; Cheng Z; Liu F; Han Z; Yu X; Yu J; Liang P
J Ultrasound Med; 2023 Dec; 42(12):2825-2838. PubMed ID: 37713625
[TBL] [Abstract][Full Text] [Related]
8. Contrast-enhanced ultrasonography in the evaluation of incidental focal liver lesions: A cost-effectiveness analysis.
Smajerova M; Petrasova H; Little J; Ovesna P; Andrasina T; Valek V; Nemcova E; Miklosova B
World J Gastroenterol; 2016 Oct; 22(38):8605-8614. PubMed ID: 27784973
[TBL] [Abstract][Full Text] [Related]
9. Contrast-enhanced ultrasound (CEUS) has excellent diagnostic accuracy in differentiating focal liver lesions: results from a Swiss tertiary gastroenterological centre.
Sawatzki M; Meyenberger C; Brand S; Semela D
Swiss Med Wkly; 2019 Jun; 149():w20087. PubMed ID: 31256416
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic accuracy and clinical impact of MRI-based technologies for patients with non-alcoholic fatty liver disease: systematic review and economic evaluation.
Bresnahan R; Duarte R; Mahon J; Beale S; Chaplin M; Bhattacharyya D; Houten R; Edwards K; Nevitt S; Maden M; Boland A
Health Technol Assess; 2023 Jul; 27(10):1-115. PubMed ID: 37839810
[TBL] [Abstract][Full Text] [Related]
11. Contrast-enhanced ultrasound for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.
Fraquelli M; Nadarevic T; Colli A; Manzotti C; Giljaca V; Miletic D; Štimac D; Casazza G
Cochrane Database Syst Rev; 2022 Sep; 9(9):CD013483. PubMed ID: 36053210
[TBL] [Abstract][Full Text] [Related]
12. Fusion imaging of contrast-enhanced ultrasound and contrast-enhanced CT or MRI before radiofrequency ablation for liver cancers.
Bo XW; Xu HX; Wang D; Guo LH; Sun LP; Li XL; Zhao CK; He YP; Liu BJ; Li DD; Zhang K
Br J Radiol; 2016 Nov; 89(1067):20160379. PubMed ID: 27626506
[TBL] [Abstract][Full Text] [Related]
13. A Milestone: Approval of CEUS for Diagnostic Liver Imaging in Adults and Children in the USA.
Seitz K; Strobel D
Ultraschall Med; 2016 Jun; 37(3):229-32. PubMed ID: 27276056
[TBL] [Abstract][Full Text] [Related]
14. Detection and characterisation of liver metastases.
Albrecht T; Hohmann J; Oldenburg A; Skrok J; Wolf KJ
Eur Radiol; 2004 Oct; 14 Suppl 8():P25-33. PubMed ID: 15700330
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic accuracy of contrast-enhanced ultrasound in differentiating benign and malignant focal liver lesions: a retrospective study.
Ooi CC; Low SC; Schneider-Kolsky M; Lombardo P; Lim SY; Abu Bakar R; Lo RH
J Med Imaging Radiat Oncol; 2010 Oct; 54(5):421-30. PubMed ID: 20958940
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic accuracy of CEUS in the differential diagnosis of small (≤ 20 mm) and subcentimetric (≤ 10 mm) focal liver lesions in comparison with histology. Results of the DEGUM multicenter trial.
Strobel D; Bernatik T; Blank W; Schuler A; Greis C; Dietrich CF; Seitz K
Ultraschall Med; 2011 Dec; 32(6):593-7. PubMed ID: 22161556
[TBL] [Abstract][Full Text] [Related]
17. Systematic review and modelling of the cost-effectiveness of cardiac magnetic resonance imaging compared with current existing testing pathways in ischaemic cardiomyopathy.
Campbell F; Thokala P; Uttley LC; Sutton A; Sutton AJ; Al-Mohammad A; Thomas SM
Health Technol Assess; 2014 Sep; 18(59):1-120. PubMed ID: 25265259
[TBL] [Abstract][Full Text] [Related]
18. Total hip replacement and surface replacement for the treatment of pain and disability resulting from end-stage arthritis of the hip (review of technology appraisal guidance 2 and 44): systematic review and economic evaluation.
Clarke A; Pulikottil-Jacob R; Grove A; Freeman K; Mistry H; Tsertsvadze A; Connock M; Court R; Kandala NB; Costa M; Suri G; Metcalfe D; Crowther M; Morrow S; Johnson S; Sutcliffe P
Health Technol Assess; 2015 Jan; 19(10):1-668, vii-viii. PubMed ID: 25634033
[TBL] [Abstract][Full Text] [Related]
19. Ablative safety margin depicted by fusion imaging with post-treatment contrast-enhanced ultrasound and pre-treatment CECT/CEMRI after radiofrequency ablation for liver cancers.
Bo XW; Xu HX; Guo LH; Sun LP; Li XL; Zhao CK; He YP; Liu BJ; Li DD; Zhang K; Wang D
Br J Radiol; 2017 Oct; 90(1078):20170063. PubMed ID: 28749166
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
